New Retina Radio
New Retina Radio

06.20.24

A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World

Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patients with macular edema. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc.

View full description +

MORE EPISODES

09.04.25

ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR

David Lally, MD; and Ehsan Rahimy, MD

08.21.25

ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders

John Kitchens, MD; Krishna Mukkamala, MD

07.21.25

The State of Geographic Atrophy Around the Globe: Part 2 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

07.21.25

The State of Geographic Atrophy Around the Globe: Part 1 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

07.18.25

Diabetic Retinopathy Severity and Income Status

Ben Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD

07.07.25

GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

07.07.25

GA in 2025: Dosing Regimens, Drug Selection, and Ideal Candidates

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

Show More